To determine first whether targeting GLUT1 with WZB117 inhibits the tumor-initiating capacity of PANC-1 CSLCs, we examined, after pretreatment with WZB117 in vitro, their ability to initiate tumors upon xenotransplantation into nude mice. This evidence concerns the gene SLC2A1 and neoplasm.